US2005014715A1PendingUtilityA1
Inosine compounds and their use for treating or preventing an inflammation or reperfusion disease
Priority: Dec 2, 1998Filed: Aug 12, 2004Published: Jan 20, 2005
Est. expiryDec 2, 2018(expired)· nominal 20-yr term from priority
A61K 31/00Y02A50/30A61K 45/06C07H 19/16A61K 31/7076
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Inosine compounds, compositions comprising an inosine compound and methods for treating or preventing an inflammation disease or a reperfusion disease comprising administering an effective amount of an inosine compound to a patient in need thereof are disclosed.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 . A method for treating a reperfusion disease, comprising administering to a patient in need thereof an effective amount of a compound of formula I:
or a pharmaceutically acceptable salt thereof, wherein:
R 1 is C 2 -C 6 acyl, SO 3 H, P 2 O 6 H 3 or P 3 O 9 H 4 ; and
R 2 , R 3 and R 4 are independently H, C 2 -C 6 acyl, SO 3 H, PO 3 H 2 , P 2 O 6 H 3 or P 3 O 9 H 4 .
11 . The method of claim 10 , wherein
R 1 is C 2 -C 6 acyl, SO 3 H, P 2 O 6 H 3 , P 3 O 9 H 4 or a pharmaceutically acceptable salt thereof; and R 2 , R 3 and R 4 are H.
12 . The method of claim 10 , wherein R 1 is —SO 3 H, or a pharmaceutically acceptable salt thereof.
13 . The method of claim 10 , wherein R 1 is P 2 O 6 H 3 , or a pharmaceutically acceptable salt thereof.
14 . The method of claim 10 , wherein R 1 is P 3 O 9 H 4 , or a pharmaceutically acceptable salt thereof.
15 . The method of claim 10 , wherein R 1 is C 2 -C 6 acyl.
16 . The method of claim 15 , wherein the C 2 -C 6 acyl is acetyl.
17 . The method of claim 10 , wherein the reperfusion disease is hemorrhagic shock, septic shock, sepsis, a disease caused by solid organ transplantation, cadiopulmonary bypass surgery, compartment syndrome, crush injury, splanchnic ischemia-reperfusion, myocardial infarction and stroke.
18 - 75 . (canceled)
76 . The method of claim 10 , wherein R 2 , R 3 , and R 4 are each hydrogen, and R 1 is —SO 3 − Na + .Join the waitlist — get patent alerts
Track US2005014715A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.